Alzamend Neuro Inc (ALZN)
0.67
+0.02
(+3.24%)
USD |
NASDAQ |
May 17, 16:00
0.67
0.00 (0.00%)
After-Hours: 20:00
Alzamend Neuro Total Assets (Quarterly): 0.7826M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 0.7826M |
| October 31, 2023 | 0.9836M |
| July 31, 2023 | 2.628M |
| April 30, 2023 | 5.916M |
| January 31, 2023 | 8.502M |
| October 31, 2022 | 10.42M |
| July 31, 2022 | 12.21M |
| Date | Value |
|---|---|
| April 30, 2022 | 14.52M |
| January 31, 2022 | 12.43M |
| October 31, 2021 | 14.50M |
| July 31, 2021 | 16.82M |
| April 30, 2021 | 2.913M |
| January 31, 2021 | 0.802M |
| April 30, 2020 | 1.814M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.7826M
Minimum
Jan 2024
16.82M
Maximum
Jul 2021
7.517M
Average
7.209M
Median
Total Assets (Quarterly) Benchmarks
| Retractable Technologies Inc | 179.67M |
| BioCardia Inc | 2.679M |
| Summit Therapeutics Inc | 176.78M |
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 19.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.046M |
| Shareholders Equity (Quarterly) | -4.264M |